Researchers have discovered how to use hot water treatment to meet market entry protocols for fruit fly disinfestation in Australian...
Advances in the treatment of Multiple Sclerosis have been good news for patients, but side effects and risks mean that an active management strategy and constant monitoring are essential.
Your morning coffee could now give an added immunity boost, thanks to postbiotics and Griffith University and CSIRO researchers.
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord injury is a step closer with a $6.8 million Medical Research Future Fund grant.
The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
Nine new Griffith-led ARC Discovery Projects awarded $3,622,738.
In this instalment of Griffith University’s Better Future for All series, journalist Kerry O’Brien explores the future and impact of AI with leading global thinker Professor Toby Walsh.
Three Griffith University research projects have been successful in gaining grants from the Medical Research Future Fund (MRFF).
Griffith University is seeking five people living with spinal cord injury to be part of stage two of an innovative trial which will test intensive rehabilitation for those living with chronic spinal cord paralysis.
